Physician profile
Osayawe N Odeh
NPI 1245255819
$422.85
in general payments reported to CMS, 2019-2025
10 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.01 · 2020: $13.31 · 2021: $40.85 · 2023: $77.88 · 2024: $114 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $324.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $118.37 | 2019-2025 | Collagenase Santyl, Regranex |
| Kerecis Limited | $111.80 | 2021-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Convatec INC. | $53.61 | 2023 | |
| Organogenesis INC. | $24.27 | 2023 | Puraply |
| Reapplix INC. | $23.27 | 2025 | 3c Patch Kit - Box |
| Advanced Oxygen Therapy INC. | $21.85 | 2025 | Topical Oxygen Chamber For Extremities |
| Urgo Medical North America, LLC | $21.72 | 2024 | Urgok2 |
| Reprise Biomedical, INC. | $19.11 | 2025 | Miro 3d |
| Kci USA, INC. | $17.87 | 2021 | |
| Novartis Pharmaceuticals Corporation | $10.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Osayawe Odeh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.